These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 24894770

  • 1. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.
    Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL, Feldman AL.
    Biomark Med; 2015 Aug 28; 9(8):719-22. PubMed ID: 26223379
    [No Abstract] [Full Text] [Related]

  • 5. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
    Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL.
    Blood; 2018 Sep 27; 132(13):1386-1398. PubMed ID: 30093402
    [Abstract] [Full Text] [Related]

  • 6. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
    Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL.
    Hum Pathol; 2017 Jun 27; 64():19-27. PubMed ID: 28153507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma.
    Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S.
    Am J Surg Pathol; 2022 Nov 01; 46(11):1490-1499. PubMed ID: 35941721
    [Abstract] [Full Text] [Related]

  • 10. ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
    Parkhi M, Bal A, Das A, Kashyap D, Bhardwaj S, Prakash G, Malhotra P.
    Appl Immunohistochem Mol Morphol; 2021 Oct 01; 29(9):648-656. PubMed ID: 33901030
    [Abstract] [Full Text] [Related]

  • 11. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
    Irshaid L, Xu ML.
    Pathology; 2020 Jan 01; 52(1):100-110. PubMed ID: 31706671
    [Abstract] [Full Text] [Related]

  • 12. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL.
    Appl Immunohistochem Mol Morphol; 2015 Sep 01; 23(8):580-9. PubMed ID: 25390351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
    Magaki S, Satyadev R, Chen Z, Yung KS, Vinters HV, Kinney MC, Said JW.
    Brain Tumor Pathol; 2022 Jan 01; 39(1):25-34. PubMed ID: 34791573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Robert K, Villa D, Sehn LH, Connors JM, Gascoyne RD, Feldman AL, Farinha P, Steidl C, Scott DW, Slack GW, Savage KJ.
    Br J Haematol; 2019 Aug 01; 186(3):e28-e31. PubMed ID: 30873584
    [No Abstract] [Full Text] [Related]

  • 20. Co-occurring rearrangements of DUSP22 and TP63 define a rare genetic subset of ALK-negative anaplastic large cell lymphoma with inferior survival outcomes.
    Klairmont MM, Ward N.
    Leuk Lymphoma; 2022 Feb 01; 63(2):506-508. PubMed ID: 34612143
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.